期刊文献+

B7/CD28家族共刺激分子在蒙古族儿童的川崎病发病机制中的作用 被引量:1

The Role of the B7/CD28 Costimulatory Molecules Family in the Pathogenesis of Kawasaki Disease on Mongolia Children
下载PDF
导出
摘要 目的:阐明B7/CD28家族刺激分子在蒙古族儿童川崎病的发病机制中起到的重要作用。方法:通过荧光定量PCR对蒙古族儿童川崎病患者和用IVIG后ICOS和CTLA-4mRNA表达量变化进行研究。结果:川崎病组CTLA-4mRNA表达水平显著降低,比较有显著性差异(P<0.05),而ICOSmRNA表达水平显著增高,差异显著(P<0.05)。川崎病IVIG治疗组ICOSmRNA的表达显著降低(P<0.05),CTLA-4mRNA表达显著升高(P<0.05)。结论:B7/CD28家族成员中的活化及抑制作用,以及它们之间的相互关系,不仅可以探讨川崎病的发病机制,而且可能为它的免疫治疗提供新的思路。进而更好地为少数民族儿童的身体健康提供基础。 Objective:The B7/CD28 family of costimulatory molecules in the pathogenesis of Kawasaki disease Mongolian children played important roles.Methods: Mongolian children with Kawasaki disease,and after using IVIG,changes expression of the ICOS and CTLA-4mRNA level was detected by Quantitative PCR.Results: CTLA-4mRNA expression level of Kawasaki disease was lower(P〈0.05),but the ICOS mRNA was higher(P〈0.05).In the IVIG treatment group,the ICOS mRNA level was lower,and the CTLA4 mRNA was higher(P〈0.05).Conclusion: As the main pathological changes in autoimmune vasculitis syndrome,kawasaki disease(KD) is an inflammation of small artery disease.B7/CD28 family members which can provide the second signal molecule T cell immune response abnormalities may be important in the pathogenesis.To better serve the health of minority children,this study provide a theoretical basis.
作者 马慧芳
出处 《内蒙古医学杂志》 2010年第10期1167-1170,共4页 Inner Mongolia Medical Journal
关键词 川崎病 CTLA-4 ICOS 蒙古族儿童 Kawasaki disease CTLA-4 ICOS Mongolian children
  • 相关文献

参考文献9

  • 1黄国英.川崎病流行病学现状[J].中国实用儿科杂志,2006,21(10):721-723. 被引量:46
  • 2王国兵,李成荣,祖莹,袁雄伟.Toll样受体信号途径活化在川崎病免疫发病机制中的作用[J].中华儿科杂志,2006,44(5):333-336. 被引量:22
  • 3KitamuraS,Tsuda E,Kobayashi J,et al.Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease[J].Circulation,2009,120:60-8.
  • 4Faleini F.Kawasaki disease[J].Curr Opin Rheumatol,2006,18:33-38.
  • 5Hung MC,wu KG,Hwang B,et al.Kawasaki disease resembling a retropharyngeal abscess--case report and literature review[J].Int J Cardiol,2007,115:94-96.
  • 6Beier KC,Hutloff A,Dittrich AM,et al.Induction,binding specificity and function of human ICOS[J].Eur J Immunol,2000,30(12):3707.
  • 7Burmeister Y,Lischke T,Dahler AC,et al.ICOS controls the pool size of effector-memory and regulatory T eells[J].J Immunol,2008,180(2):774.
  • 8Maker AV,Phan GQ,Attia P,et al.Tunaor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-assoeiated antigen 4 blockade and interleukin 2:a phase I/II study[J].Ann Surg Oncol,2005,12:1005-1016.
  • 9Schneider H,Downey J,Smith A,et al.Reversal of the TCR stop signal by CTLA-4[J].Science,2006,313:1972-1975.

二级参考文献35

  • 1梁翊常,王乃坤,赵欣军.1987~1991年78所医院川崎病住院患儿发病调查[J].临床儿科杂志,1994,12(5):319-320. 被引量:30
  • 2李晓辉,李晓静,李蕙,王晓蕾,徐鸣,张拓红,柳川洋,川崎富作.1997-2001年四川省川崎病流行病学调查[J].临床儿科杂志,2006,24(4):306-308. 被引量:20
  • 3黄国英,马晓静,黄敏,陈树宝,黄美蓉,邱定忠,过仲珍,蒋瑾瑾,周晓迅,于清,桂永浩,宁寿葆,张拓红,杜忠东,Hiroshi Yanagawa,Tomisaku Kawasaki.上海地区1998-2002年川崎病流行病学特征[J].中国循证儿科杂志,2006,1(1):8-13. 被引量:62
  • 4Kawasaki T.Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children (in Japanese)[J].Jpn J Allergy,1967,16 (3):178 -222.
  • 5Zhang T,Yanagawa H,Nakamura Y.The profiles of Kawasaki disease in China[J].J Epidemiol,2001,11 (3):103-108.
  • 6Yanagawa H,Nakamura Y,Yashiro M,et al.Incidence survey of Kawasaki disease in 1997 and 1998 in Japan[J].Pediatrics,2001,107(3):33.
  • 7Park YW,Han JW,Park IS,et al.Epidemiologic picture of Kawasaki disease in Korea,2000-2002[J].Pediatr Int,2005,47(4):382-387.
  • 8Lue HC,Philip S,Chen MR,et al.Surveillance of Kawasaki disease in Taiwan and review of the literature[J].Acta Paediatr Taiwan,2004,45(1):8-14.
  • 9Chang LY,Chang IS,Lu CY,et al.Epidemiologic features of Kawasaki disease in Taiwan,1996-2002[J].Pediatrics,2004,114(6):678-682
  • 10Ng YM,Sung RY,So LY,et al.Kawasaki disease in Hong Kong[J].Hong Kong Med J,2005,11 (5):331-335.

共引文献66

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部